Cantor Fitzgerald started coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $9.00 price target on the stock.
Separately, Barclays began coverage on shares of Anteris Technologies Global in a research note on Tuesday. They set an “overweight” rating and a $22.00 price objective for the company.
Check Out Our Latest Stock Analysis on Anteris Technologies Global
Anteris Technologies Global Stock Performance
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Expert Stock Trading Psychology Tips
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
